A detailed history of New Mexico Educational Retirement Board transactions in Moderna, Inc. stock. As of the latest transaction made, New Mexico Educational Retirement Board holds 16,300 shares of MRNA stock, worth $600,655. This represents 0.04% of its overall portfolio holdings.

Number of Shares
16,300
Previous 16,700 2.4%
Holding current value
$600,655
Previous $1.98 Million 45.08%
% of portfolio
0.04%
Previous 0.07%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$63.64 - $125.14 $25,456 - $50,056
-400 Reduced 2.4%
16,300 $1.09 Million
Q1 2024

Apr 23, 2024

SELL
$85.37 - $115.44 $324,406 - $438,672
-3,800 Reduced 18.54%
16,700 $1.78 Million
Q1 2024

Apr 17, 2024

BUY
$85.37 - $115.44 $290,258 - $392,496
3,400 Added 19.88%
20,500 $3.53 Million
Q3 2023

Nov 01, 2023

BUY
$96.41 - $126.61 $96,410 - $126,610
1,000 Added 6.21%
17,100 $1.77 Million
Q2 2023

Jul 17, 2023

BUY
$118.5 - $160.53 $94,800 - $128,424
800 Added 5.23%
16,100 $1.96 Million
Q1 2023

May 03, 2023

SELL
$135.66 - $197.02 $67,830 - $98,510
-500 Reduced 3.16%
15,300 $2.35 Million
Q4 2022

Feb 01, 2023

SELL
$118.38 - $210.04 $224,922 - $399,076
-1,900 Reduced 10.73%
15,800 $2.84 Million
Q3 2022

Oct 18, 2022

SELL
$118.07 - $194.18 $224,333 - $368,942
-1,900 Reduced 9.69%
17,700 $2.09 Million
Q2 2022

Jul 21, 2022

SELL
$117.13 - $176.59 $105,417 - $158,931
-900 Reduced 4.39%
19,600 $2.8 Million
Q1 2022

Apr 01, 2022

SELL
$126.46 - $235.05 $126,460 - $235,050
-1,000 Reduced 4.65%
20,500 $3.53 Million
Q4 2021

Jan 19, 2022

SELL
$225.82 - $368.51 $338,730 - $552,765
-1,500 Reduced 6.52%
21,500 $5.46 Million
Q3 2021

Oct 19, 2021

BUY
$221.9 - $484.47 $5.1 Million - $11.1 Million
23,000 New
23,000 $8.85 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track New Mexico Educational Retirement Board Portfolio

Follow New Mexico Educational Retirement Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Mexico Educational Retirement Board, based on Form 13F filings with the SEC.

News

Stay updated on New Mexico Educational Retirement Board with notifications on news.